Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT00820326 Completed - Fibromyalgia Clinical Trials

Efficacy of Dolasetron in Patients With Fibromyalgia

Dolastron
Start date: March 2004
Phase: Phase 3
Study type: Interventional

This study offers a new treatment, dolasetron or ANZEMET ®, which will be administered by intravenous way once a day during a 4 days Hospitalization. This study is double blind (neither you nor the physician will know if you are receiving active study drug or placebo). Randomisation at the beginning of the study will decide whether you receive active treatment or its placebo. This treatment will be renewed after one month, after 2 months and after 3 months. If the study staff determines that you are eligible and you decide to participate, there will be approximately 6 study visits in about 9 months. During these visits, you will undergo routine health exams and complete different kinds of questionnaires. Following this first period of 3 months, you agree to come back for consultation at month 4, month 6 and month 12 for monitoring and evaluating the effects of treatment.

NCT ID: NCT00819624 Completed - Fibromyalgia Clinical Trials

A Study to Compare Two Ways of Completing Pain and Sleep Questions and to Evaluate a New Daily Questionaire for Assessing Fatigue in Fibromyalgia Patients

Start date: January 2009
Phase: N/A
Study type: Interventional

The study has two goals. The first goal of the study is to compare two methods of administering questions about pain and sleep interference. The two methods being compared are a telephone based system and an electronic hand held diary. The second goal of the study is to evaluate a daily diary to evaluate fatigue symptoms in patients with fibromyalgia.

NCT ID: NCT00803023 Completed - Fibromyalgia Clinical Trials

Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia

Start date: March 2010
Phase: Phase 3
Study type: Interventional

To compare the safety and tolerability of sodium oxybate given as a combination of an oral solution and oral tablets for 4 weeks in subjects with fibromyalgia (FM).

NCT ID: NCT00797797 Completed - Fibromyalgia Clinical Trials

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

Start date: November 2008
Phase: Phase 3
Study type: Interventional

To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.

NCT ID: NCT00796601 Withdrawn - Fibromyalgia Clinical Trials

Maintenance of Efficacy.

Start date: May 1, 2009
Phase: Phase 3
Study type: Interventional

The hypothesis of Study A6061054 is to demonstrate superiority of efficacy of esreboxetine at 3 and 6 months compared to placebo.

NCT ID: NCT00795106 Withdrawn - Clinical trials for Myofascial Pain Syndrome

Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain

Start date: November 2009
Phase: Phase 2
Study type: Interventional

Chronic neck pain is a common condition that can negatively impact quality of life. Substance P is one of the chemicals in the body that can transmit pain signals from overloaded neck muscles to the brain. Topical capsaicin blocks the action of Substance P by releasing, and subsequently depleting the body's store of Substance P in the nerves. Topical capsaicin has been reported to be an effective therapy for a number of persistent pain conditions including diabetic neuropathy, post-herpetic neuralgia, osteoarthritis, rheumatoid arthritis, and post-mastectomy pain. This study will evaluate the efficacy of topical capsaicin to reduce pain and improve health-related quality of life in adults with chronic muscular neck pain.

NCT ID: NCT00793520 Terminated - Fibromyalgia Clinical Trials

Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of milnacipran on how the brain processes pain in patients with fibromyalgia and to assess the relationship between this effect and brain activation patterns during functional magnetic resonance imaging.

NCT ID: NCT00791739 Completed - Fibromyalgia Clinical Trials

Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The study has a double purpose: a first phase intends to assess the effectiveness and tolerability of trazodone, an antidepressant with sedative and sleep-promoting properties, in the treatment of fibromyalgia; a second phase intends to evaluate if the addition of pregabalin to patients who have shown a partial response to trazodone additionally improves fibromyalgia symptomatology.

NCT ID: NCT00789178 Not yet recruiting - Fibromyalgia Clinical Trials

Cognitive and Memory Function in Patients With Fibromyalgia

Start date: December 2008
Phase: N/A
Study type: Observational

Patients suffering from Fibromyalgia will be examined for the presence of memory and/or cognitive impairment using specific psychological tests. Their results will be compared to those with active RA associated with pain and with a normal control group.

NCT ID: NCT00766675 Completed - Pain Clinical Trials

An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the analgesic effect of combination of tramadol hydrochloride and acetaminophen in participants for treatment of fibromyalgia pain (chronic widespread pain and presence of tender points).